SeraCare's aneuploidy reference materials will be incorporated into a quality assessment program being developed by the UK National External Quality Assessment Service.
Natera has focused on tapping into the average risk market for its suite of noninvasive prenatal assays, which it said is paying off.
The company's revenues were driven by sales of its Panorama NIPT and Horizon carrier screening tests.
The researchers also uncovered unique biology about the cell-free DNA fragments, identifying nucleotide patterns at the ends of the molecules.
By offering NIPT as a secondary screening test, the UK hopes to reduce the number of invasive diagnostic tests and associated miscarriages.
Several academic and commercial groups are developing clinical cell-based noninvasive prenatal tests, which could eventually compete with current cell-free NIPTs.
The test is based on MDNA's Mitomic technology, which enables the isolation of mitochondrial DNA in circulation that may be used as biomarkers.
Following this agreement, LifeCodexx's PrenaTest is now available in more than 40 countries throughout Europe and the Middle East.
The court ordered the molecular diagnostic company to stop offering the Fetalis test it started offering in Germany this summer, which is based on Ariosa's technology.
This year, the vast majority of assays the Belgian company facilitates will be non-invasive prenatal testing, which it only started offering in 2013.
Participants of the National Society of Genetic Counselors annual education conference highlighted the need for consensus guidelines for screening potential gamete donors.
The researchers also plan to analyze how payors make coverage decisions for NGS-based gene panels, exome, and whole-genome sequencing clinical tests.
Despite recent bills that argue the advent of NIPS will increase abortion, researchers say that there is not yet enough data.
Cystic fibrosis carrier status often did not impact family planning decisions and was sometimes perceived as a risk to unaffected family members.
The findings, published last week, have prompted Belgian medical genetics centers to routinely report maternal incidental findings from NIPT.
The $302 million deal, which was expected to close by the end of the year, passed US government antitrust review in August.
Last week, the G-BA, a committee that decides about reimbursable medical services in Germany, said it will start a methods evaluation of noninvasive prenatal testing.
Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.
The study adds to a growing body of evidence suggesting that expanded carrier screening tests can better identify at-risk couples.
CombiMatrix said the move will increase access to the test in the state for women experiencing recurrent pregnancy loss.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.